Literature DB >> 8471835

Direct correlation between MUC18 expression and metastatic potential of human melanoma cells.

M Luca1, B Hunt, C D Bucana, J P Johnson, I J Fidler, M Bar-Eli.   

Abstract

The expression of the glycoprotein MUC18 in melanoma biopsies has previously been shown to increase with increasing tumour thickness, and thus to correlate with the probability of metastasis development. We have examined the expression of this molecule by nine human melanoma cell lines with known metastatic ability (both spontaneous and experimental) in nude mice. Examination of the expression of both the MUC18 mRNA and of the glycoprotein on the cell surface revealed a statistically significant correlation (P = 0.040) between its expression and the ability to form metastases in vivo. Although MUC18 shows sequence similarity to neural cell adhesion molecules, no correlation was observed between the site of origin of the metastatic lesions (brain, lymph node) and MUC18 expression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8471835     DOI: 10.1097/00008390-199304000-00006

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  32 in total

1.  Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis.

Authors:  M Luca; S Huang; J E Gershenwald; R K Singh; R Reich; M Bar-Eli
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

2.  Transcriptional modulation of genes encoding structural characteristics of differentiating enterocytes during development of a polarized epithelium in vitro.

Authors:  Jennifer M Halbleib; Annika M Sääf; Patrick O Brown; W James Nelson
Journal:  Mol Biol Cell       Date:  2007-08-15       Impact factor: 4.138

3.  Quantitative analysis of surface plasma membrane proteins of primary and metastatic melanoma cells.

Authors:  Haibo Qiu; Yinsheng Wang
Journal:  J Proteome Res       Date:  2008-04-15       Impact factor: 4.466

4.  MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule).

Authors:  W G Degen; L C van Kempen; E G Gijzen; J J van Groningen; Y van Kooyk; H P Bloemers; G W Swart
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

Review 5.  Recent advances in the treatment of malignant melanoma with gene therapy.

Authors:  E M Hersh; A T Stopeck
Journal:  Mol Med       Date:  1997-10       Impact factor: 6.354

6.  ZBTB7A Suppresses Melanoma Metastasis by Transcriptionally Repressing MCAM.

Authors:  Xue-Song Liu; Matthew D Genet; Jenna E Haines; Elie K Mehanna; Shaowei Wu; Hung-I Harry Chen; Yidong Chen; Abrar A Qureshi; Jiali Han; Xiang Chen; David E Fisher; Pier Paolo Pandolfi; Zhi-Min Yuan
Journal:  Mol Cancer Res       Date:  2015-05-20       Impact factor: 5.852

7.  Melanoma Cell Galectin-1 Ligands Functionally Correlate with Malignant Potential.

Authors:  Erika M Yazawa; Jenna E Geddes-Sweeney; Filiberto Cedeno-Laurent; Kempland C Walley; Steven R Barthel; Matthew J Opperman; Jennifer Liang; Jennifer Y Lin; Tobias Schatton; Alvaro C Laga; Martin C Mihm; Abrar A Qureshi; Hans R Widlund; George F Murphy; Charles J Dimitroff
Journal:  J Invest Dermatol       Date:  2015-03-10       Impact factor: 8.551

8.  Up-regulation of MUC18 in airway epithelial cells by IL-13: implications in bacterial adherence.

Authors:  Glenn C Simon; Richard J Martin; Sean Smith; Jyoti Thaikoottathil; Russell P Bowler; Stephen J Barenkamp; Hong Wei Chu
Journal:  Am J Respir Cell Mol Biol       Date:  2011-01-14       Impact factor: 6.914

9.  PAX3 expression in normal skin melanocytes and melanocytic lesions (naevi and melanomas).

Authors:  Sandra Medic; Mel Ziman
Journal:  PLoS One       Date:  2010-04-22       Impact factor: 3.240

10.  Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis.

Authors:  S Huang; D Jean; M Luca; M A Tainsky; M Bar-Eli
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.